<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39318068</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1941-5923</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>The American journal of case reports</Title><ISOAbbreviation>Am J Case Rep</ISOAbbreviation></Journal><ArticleTitle>Complex Interplay of COVID-19 ARDS with Guillain-Barré Syndrome and Cerebral Infarction: A Case Study.</ArticleTitle><Pagination><StartPage>e944390</StartPage><MedlinePgn>e944390</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/AJCR.944390</ELocationID><Abstract><AbstractText>BACKGROUND Coronavirus disease (COVID-19) can cause various complications. We report a case of severe COVID-19 acute respiratory distress syndrome (ARDS) in a patient receiving veno-venous extracorporeal membrane oxygenation (V-V ECMO), complicated by Guillain-Barre syndrome (GBS) and cerebral infarction, as well as pulmonary embolism. CASE REPORT A 55-year-old Japanese man with a history of ulcerative colitis was admitted for COVID-19. His respiratory status worsened and progressed to ARDS, requiring intubation on hospital day (HD) 3. On HD 16, contrast computed tomography revealed PE. On HD 18, his respiratory condition worsened, and V-V ECMO was initiated. On HD 23, V-V ECMO was successfully discontinued. He regained consciousness on HD 44, but he had quadriplegia. Deep-tendon reflexes were absent in all limbs. Cranial nerve involvement, specifically bilateral facial nerve weakness, was noted. Magnetic resonance imaging showed bilateral scattered cerebral infarctions on HD 76. Nerve conduction studies indicated severe axonal neuropathy. Cerebrospinal fluid examination showed albuminocytologic dissociation. The antibody to the ganglioside GD1a was positive. These findings were consistent with the diagnosis of GBS. He received immunoglobulin treatment on HD 89, and his neurological findings slightly improved. CONCLUSIONS This study emphasized that in COVID-19, neurological complications are not rare, are difficult to diagnose, and are prone to delays in detection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morikawa</LastName><ForeName>Daiki</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujitani</LastName><ForeName>Shigeki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirahige</LastName><ForeName>Tomoyuki</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0458-3090</Identifier><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>Yuta</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morisawa</LastName><ForeName>Kenichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Case Rep</MedlineTA><NlmUniqueID>101489566</NlmUniqueID><ISSNLinking>1941-5923</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="Y">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002544" MajorTopicYN="Y">Cerebral Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39318068</ArticleId><ArticleId IdType="pmc">PMC11441711</ArticleId><ArticleId IdType="doi">10.12659/AJCR.944390</ArticleId><ArticleId IdType="pii">944390</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon RT, Wijaya VO, Buana RB, et al. Neurologic characteristics in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Front Neurol. 2020;11:565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273516</ArticleId><ArticleId IdType="pubmed">32574250</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Wu L, Ni F, et al. Critical illness polyneuropathy and myopathy: A systematic review. Neural Regen Res. 2014;9(1):101–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4146320</ArticleId><ArticleId IdType="pubmed">25206749</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregson NA, Koblar S, Hughes RA. Antibodies to gangliosides in Guillain-Barré syndrome: Specificity and relationship to clinical features. Q J Med. 1993;86(2):111–17.</Citation><ArticleIdList><ArticleId IdType="pubmed">8464986</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sanctis P, Doneddu PE, Viganò L, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection. A systematic review. Eur J Neurol. 2020;27(11):2361–70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436512</ArticleId><ArticleId IdType="pubmed">32757404</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada S, Nagasaki Y, Arimizu Y, et al. Neurological disorders identified during treatment of a SARS-CoV-2 infection. Intern Med. 2020;59(17):2187–89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7516316</ArticleId><ArticleId IdType="pubmed">32713924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cea G, Romero C, Aguilar S, Salinas R. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases. Rev Med Chile. 2021;149(12):1812–16.</Citation><ArticleIdList><ArticleId IdType="pubmed">35735350</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajdev K, Victor N, Buckholtz ES, et al. A case of Guillain-Barré syndrome associated with COVID-19. J Investig Med High Impact Case Rep. 2020;8 2324709620961198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7545753</ArticleId><ArticleId IdType="pubmed">32981333</ArticleId></ArticleIdList></Reference><Reference><Citation>Rane RP, Jain A, Hussain KM, et al. A rare case of Guillain-Barré syndrome associated with SARS-CoV-2 infection requiring mechanical ventilation. Cureus. 2022;14(6):e25810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9191260</ArticleId><ArticleId IdType="pubmed">35720780</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiu AC, Hussain A, Okonkwo UA, et al. Guillain-Barré syndrome associated with COVID-19 pneumonia – the first documented case in a U.S. Military Intensive Care Unit. Military Medicine. 2023;188(3–4):e852–e56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083206</ArticleId><ArticleId IdType="pubmed">33881526</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz P, Leveque M, Hautecloque G, et al. The challenge of diagnosing Guillain-Barré syndrome in patients with COVID-19 in the intensive care unit. J Neuroimmunol. 2022;366:577842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8897835</ArticleId><ArticleId IdType="pubmed">35339941</ArticleId></ArticleIdList></Reference><Reference><Citation>Labbad I, Shammas I, Abbas A, et al. Guillan-Barré syndrome during COVID-19 pandemic: A case series from Syria. Ann Med Surgery (Lond) 2023;85(6):3166–70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10289577</ArticleId><ArticleId IdType="pubmed">37363509</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhom F, Sandhu H. Guillain-Barré syndrome in a patient with COVID-19 infection. Cureus. 2021;13(8):e17052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428162</ArticleId><ArticleId IdType="pubmed">34522530</ArticleId></ArticleIdList></Reference><Reference><Citation>Okhovat AA, Ansari B, Hemasian H, et al. Guillain-Barré syndrome in patients with coronavirus disease-2019: Report of six cases and review of literature. Curr J Neurol. 2020;19(3):122–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8185583</ArticleId><ArticleId IdType="pubmed">38011403</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb S, Wallace VC, Martin-Lopez D, Yogarajah M. Guillain-Barré syndrome following COVID-19: A newly emerging post-infectious complication. BMJ Case Rep. 2020;13(6):e236182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10577730</ArticleId><ArticleId IdType="pubmed">32540883</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>